The effect of intra- and postoperative allogenic blood transfusion on patients’ survival undergoing radical cystectomy for urothelial carcinoma of the bladder

World Journal of Urology

Volumn 32, Issue 6, 2014, Pages 1447-1453

  Gierth, M ^a   Aziz, A ^a   Fritsche, H M ^a   Burger, M ^a   Otto, W ^a   Zeman, F ^a   Pawlik, M T ^b   Hansen, E ^a   May, M ^c   Denzinger, S ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b Department of Surgery   (Germany)

^c Urologische Klinik   (Germany)

Author keywords

Blood; Cystectomy; Transfusion; Urothelial carcinoma

Indexed keywords

ADVERSE EFFECTS; AGED; ANEMIA; BLOOD TRANSFUSION; CARCINOMA; COMPLICATION; CYSTECTOMY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; PEROPERATIVE CARE; POSTOPERATIVE CARE; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS; UROTHELIUM;

AGED; ANEMIA; BLOOD TRANSFUSION; CARCINOMA; CYSTECTOMY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INTRAOPERATIVE CARE; MALE; MIDDLE AGED; POSTOPERATIVE CARE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 84912028426     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-014-1257-x     Document Type: Article

References (28)

1. Hollenbeck BK, Miller DC, Taub D et al. (2005) Identifying risk factors for potentially avoidable complications following radical cystectomy. J Urol 174:1231–1237; discussion 1237
2. Chang SS, Smith JA Jr, Wells N et al (2001) Estimated blood loss and transfusion requirements of radical cystectomy. J Urol 166:2151–2154
3. Busch OR, Hop WC, Hoynck van Papendrecht MA et al (1993) Blood transfusions and prognosis in colorectal cancer. N Engl J Med 328:1372–1376
4. Park KI, Kojima O, Tomoyoshi T (1997) Intra-operative autotransfusion in radical cystectomy. Br J Urol 79:717–721
5. Pisters LL, Wajsman Z (1992) Use of predeposit autologous blood and intraoperative autotransfusion in urologic cancer surgery. Urology 40:211–215
6. Klein HG (1995) Allogeneic transfusion risks in the surgical patient. Am J Surg 170:21S–26S
7. Gantt CL (1981) Red blood cells for cancer patients. Lancet 2:363
8. Ojima T, Iwahashi M, Nakamori M et al (2009) Association of allogeneic blood transfusions and long-term survival of patients with gastric cancer after curative gastrectomy. J Gastrointest Surg 13:1821–1830
9. Shiba H, Ishida Y, Wakiyama S et al (2009) Negative impact of blood transfusion on recurrence and prognosis of hepatocellular carcinoma after hepatic resection. J Gastrointest Surg 13:1636–1642
10. Wang CC, Iyer SG, Low JK et al (2009) Perioperative factors affecting long-term outcomes of 473 consecutive patients undergoing hepatectomy for hepatocellular carcinoma. Ann Surg Oncol 16:1832–1842
11. Eickhoff JH, Gote H, Baeck J (1991) Peri-operative blood transfusion in relation to tumour recurrence and death after surgery for prostatic cancer. Br J Urol 68:608–611
12. Babjuk M, Oosterlinck W, Sylvester R et al (2010) Guidelines on TaT1 (non-muscle invasive) Bladder Cancer. EAU
13. Stenzl A, Cowan NC, De Santis M et al (2010) Guidelines on muscle-invasive and metastatic bladder cancer. EAU
14. McLean E, Cogswell M, Egli I et al (2009) Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993–2005. Public Health Nutr 12:444–454
15. Charlson ME, Pompei P, Ales KL et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383
16. May M, Bastian PJ, Brookmann-May S et al (2012) External validation of a risk model to predict recurrence-free survival after radical cystectomy in patients with pathological tumor stage T3N0 urothelial carcinoma of the bladder. J Urol 187:1210–1214
17. Mackenzie G (1982) The statistical-analysis of failure time data—Kalbfleisch, Jd, Prentice, Rl. Statistician 31:278–278
18. Taniguchi Y, Okura M (2003) Prognostic significance of perioperative blood transfusion in oral cavity squamous cell carcinoma. Head Neck 25:931–936
19. Motoyama S, Okuyama M, Kitamura M et al (2004) Use of autologous instead of allogeneic blood transfusion during esophagectomy prolongs disease-free survival among patients with recurrent esophageal cancer. J Surg Oncol 87:26–31
20. Tartter PI, Burrows L, Papatestas AE et al (1985) Perioperative blood transfusion has prognostic significance for breast cancer. Surgery 97:225–230
21. Nosotti M, Rebulla P, Riccardi D et al (2003) Correlation between perioperative blood transfusion and prognosis of patients subjected to surgery for stage I lung cancer. Chest 124:102–107
22. Morgan TM, Barocas DA, Chang SS et al (2013) The relationship between perioperative blood transfusion and overall mortality in patients undergoing radical cystectomy for bladder cancer. Urol Oncol 31:871–877
23. Ghosh S, Ahmed K, Hopkinson DN et al (2004) Pulmonary adenocarcinoma is associated with poor long-term survival after surgical resection. Effect of allogeneic blood transfusion. Cancer 101:2058–2066
24. Vamvakas EC, Blajchman MA (2001) Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction? Blood 97:1180–1195
25. Bracey AW, Radovancevic R, Riggs SA et al (1999) Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcome. Transfusion 39:1070–1077
26. Butt ZM, Fazili A, Tan W et al (2009) Does the presence of significant risk factors affect perioperative outcomes after robot-assisted radical cystectomy? BJU Int 104:986–990
27. Mayr R, May M, Martini T et al (2012) Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladder. BJU Int 110:E222–E227
28. Koppie TM, Serio AM, Vickers AJ et al (2008) Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer. Cancer 112:2384–2392